companydata.dkACESION PHARMA ApS: Financial statements 2014
CVR: 34083738
ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -4,722,342 and a net result of DKK -6,455,117 compared with DKK -6,507,161 the year before. Equity amounted to DKK 3,831,501. The solvency ratio was 20.3%.
- Gross Profit
- -4,722,342 kr.
- Profit/Loss
- -6,455,117 kr.
- Equity
- 3,831,501 kr.
- Total Assets
- 18,886,932 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -4.7 mio. | -6.5 mio. | 3.8 mio. | - |
| 2013 | - | -4.8 mio. | -6.5 mio. | -556 t. | - |
| 2012 | - | -1.3 mio. | -2.1 mio. | 2 mio. | - |
Keep an eye on ACESION PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
As of August 1, 2014, Bobby G Soni has joined the board of directors of ACESION PHARMA ApS.
As of August 1, 2014, Ingelise Saunders has joined the board of directors of ACESION PHARMA ApS.
As of August 1, 2014, Carsten Schou has joined the board of directors of ACESION PHARMA ApS.
As of August 1, 2014, Frank Knudsen has left the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2013. Gross profit came to DKK -4,833,419, and the net result was DKK -6,507,161.
About ACESION PHARMA ApS
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees. In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity amounted to DKK 276,067,000.